Our search strategy for LOX in cancer research was formulated as: TS=“lysyl oxidase” OR “LOX” OR “LOXL1” OR “LOXL2” OR “LOXL3” OR “LOXL4” OR “lysyl oxidase like 1” OR “lysyl oxidase like 2” OR “lysyl oxidase like 3” OR “lysyl oxidase like 4”OR “Protein - lysine 6 - oxidase” OR “Copper - dependent amine oxidase”AND TS=(“cancer” OR “tumor” OR “neoplasm” OR “malignancy” OR “carcinoma”) NOT TS=(“lipoxygenase” OR “lactate oxidase” OR “liquid oxygen”)from 1995 to 2025. The gene discussed is LOXL3; the disease is neoplasm.